Lung health
Do you have COPD? Are you 40 – 80 years old? Diagnosed with COPD for at least 1 year? Experienced at least 1 COPD flare-up last year? Weigh 99 pounds or more with a BMI in range of 16 - 35? Current/former smoker (1+ pack/day for 10+ years)? If you qualify and choose to participate, you may receive study-related care and study medication at no cost. You may also be compensated for your time and travel. Other criteria apply – ask your doctor about the Seabreeze study. Experimental medication has not been approved by US Food and Drug Administration. ClinicalTrials.gov ID NCT06940154 Call 205-975-5294 or email epkennedy@uabmc.edu.
ZION is a clinical research study for adults with chronic obstructive pulmonary disease (COPD). This study will test a study drug injection to learn about its safety, effectiveness, and tolerability (side effects) in participants with COPD. Participation in the ZION study lasts about 32 weeks. Throughout the entire study, participants will continue to take their daily maintenance COPD medications. Who can join the ZION study? You may be able to join this study if you meet the following requirements: 40 to 75 years old Confirmed diagnosis of COPD for at least 12 months Currently taking 2 or more inhaled daily maintenance medications for COPD Other eligibility requirements will apply. Call 205-975-5294 or email epkennedy@uabmc.edu.
Opportunity to quit smoking cigarettes. Fully remote. If you smoke cigarettes every day, you may be eligible for a research study with the University of Alabama at Birmingham, in conjunctions with MUSC (The Medical University of South Carolina). The research study involves initial online screening, 8 contacts over 6 months and a chance to try varenicline, a prescription smoking cessation medication, or nicotine patches and lozenges. Items are mailed to you if eligible. Compensation is available for those who are eligible and participate. Please fill out this form for more information and to see if you are eligible.
University of Alabama at Birmingham is seeking cigarette smokers who would like to quit smoking for participation in a scientific research study. The research study involves free counseling and treatment provided in a comfortable, supportive setting. The study may involve ingestion of psilocybin, a psychoactive substance found in psychedelic mushrooms that have been used as a sacrament in various cultures. Some research studies have suggested that psychedelics, when administered under interpersonally supportive and well-prepared conditions, may be effective in helping people overcome addictions. Questionnaires, interviews, and biological measures of smoking will be used to assess the treatment's effects on mood and smoking. Participants will be compensated $50 per session. If you would like to discuss the possibility of volunteering, please call 205-996-1198, or go to www.quitsmokingbaltimore.org for more information about the study and to complete the online study prescreener for the UAB site. Confidentiality will be maintained for all applicants and participants.Volunteers must be 21 years of age or older, and must live within travel distance of the study site in Birmingham.
One Breath Matters.Are you or someone you care about age 25-35 and interested in lung health? Join the landmark Lung Health Cohort Research Study to improve the health of future generations.The pioneering NIH-funded study will follow 4,000 young, healthy adults to paint a clearer picture of lung health and the factors involved in predicting and preventing lung disease.To learn more, visit: Lung.org/lung-study.
If you have asthma, are at least 18 years of age, in the Los Angeles Region, (California) haven’t had oral steroids in at least 4 weeks, and are willing to donate 30 mL of blood, equivalent to two tablespoons, please contact Racheal Ogbebor at email Rachealogbebor@gmail.com.